开发和评估无乳糖单单元和多单元制剂的BCSII类药物里瓦罗克萨班的开发和评估
Daniel Zakowiecki1, Peter Edinger1, Markos Papaioannou1
1Chemische Fabrik Budenheim KG, Rheinstrasse 27, 55257 Budenheim, Germany.
Pharmaceutics
|November 27, 2024
概括
开发了新的无乳糖里瓦罗克萨班配方,以改善乳糖不耐症患者的口服抗凝剂治疗. 这些稳定和有效的里瓦洛克萨班片提供了一个患者友好的替代品.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 里瓦罗克萨班是一种BCSII类药物,具有较差的水溶性,使口服抗凝剂的配方复杂化.
- 乳糖不耐症的患病率越来越高,需要开发无乳糖药物.
研究的目的:
- 开发稳定,无乳糖的里瓦罗克萨班配方,包括单单元片和多单元颗粒系统 (MUPS).
- 确保这些配方符合口服抗凝药的严格的物理和性能标准.
主要方法:
- 在配方开发中使用了基于酸盐的助剂.
- 准备好的传统药片和多重单元颗粒系统 (MUPS).
- 评估物理性能 (硬度,易碎性) 和化学稳定性,以及溶解概况.
主要成果:
- 开发的里瓦洛克萨班配方表现出极好的机械强度和化学稳定性.
- 溶解概况与里瓦洛克萨班片的综合专著一致.
- 性能与参考产品Xarelto®薄膜涂层药片的性能相当.
结论:
- 成功制造出有效和稳定的无乳糖利瓦罗克萨班配方.
- 这些配方为乳糖不耐症或那些更喜欢素食选择的人提供了患者友好的替代品.
- 展示了满足现代患者需求的先进药物输送的潜力.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Bioequivalence: Overview
926
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
926
Factors Influencing Drug Absorption: Drug Dissolution
422
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
422
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121


